ID

34562

Beschrijving

Biomarkers of Remission in Rheumatoid Arthritis (BioRRA); ODM derived from: https://clinicaltrials.gov/show/NCT02219347

Link

https://clinicaltrials.gov/show/NCT02219347

Trefwoorden

  1. 19-01-19 19-01-19 -
  2. 15-04-20 15-04-20 -
  3. 16-04-20 16-04-20 - Sarah Riepenhausen
Houder van rechten

see on clinicaltrials.gov

Geüploaded op

19 januari 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Rheumatoid Arthritis NCT02219347

Eligibility Rheumatoid Arthritis NCT02219347

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
clinical diagnosis of rheumatoid arthritis made by consultant rheumatologist at least 12 months previously
Beschrijving

ID.1

Datatype

boolean

current single or combination use of methotrexate, sulphasalazine and/or hydroxychloroquine
Beschrijving

ID.2

Datatype

boolean

arthritis currently in remission, as judged clinically by referring healthcare professional
Beschrijving

ID.3

Datatype

boolean

willing to consider dmard withdrawal
Beschrijving

ID.4

Datatype

boolean

Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
use of biologic therapy within the past 6 months
Beschrijving

ID.5

Datatype

boolean

received steroids within past 3 months (enteral, parenteral or intra-articular)
Beschrijving

ID.6

Datatype

boolean

use of any dmard other than methotrexate, sulphasalazine or hydroxychloroquine within the past 6 months (or past 12 months for leflunomide)
Beschrijving

ID.7

Datatype

boolean

current pregnancy, or pregnancy planned within next 6 months
Beschrijving

ID.8

Datatype

boolean

current participation within another clinical trial
Beschrijving

ID.9

Datatype

boolean

inability to provide informed consent
Beschrijving

ID.10

Datatype

boolean

Similar models

Eligibility Rheumatoid Arthritis NCT02219347

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
clinical diagnosis of rheumatoid arthritis made by consultant rheumatologist at least 12 months previously
boolean
ID.2
Item
current single or combination use of methotrexate, sulphasalazine and/or hydroxychloroquine
boolean
ID.3
Item
arthritis currently in remission, as judged clinically by referring healthcare professional
boolean
ID.4
Item
willing to consider dmard withdrawal
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
use of biologic therapy within the past 6 months
boolean
ID.6
Item
received steroids within past 3 months (enteral, parenteral or intra-articular)
boolean
ID.7
Item
use of any dmard other than methotrexate, sulphasalazine or hydroxychloroquine within the past 6 months (or past 12 months for leflunomide)
boolean
ID.8
Item
current pregnancy, or pregnancy planned within next 6 months
boolean
ID.9
Item
current participation within another clinical trial
boolean
ID.10
Item
inability to provide informed consent
boolean

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial